OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Van Lanschot Kempen NV/  NL0000302636  /

Euronext - Amsterdam
2024-05-21  2:47:59 PM Chg. -0.850 Volume Bid2:48:42 PM Ask2:53:17 PM Market Capitalization Dividend Y. P/E Ratio
39.450EUR -2.11% 73,842
Turnover: 2.93 mill.		 39.450Bid Size: 125 39.500Ask Size: 291 1.68 bill.EUR 5.06% 14.02
GlobeNewswire 04-05 ORYZON to Provide Corporate Progress Updates at Several Events in April
GlobeNewswire 04-04 Oculis to Participate at Upcoming April Investor Conferences
GlobeNewswire 04-03 Pharming Group to participate in April investor conferences
GlobeNewswire 03-18 Transgene Announces Upcoming Investor Meetings
GlobeNewswire 03-04 Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
GlobeNewswire 02-29 MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and...
GlobeNewswire 02-08 Autolus Announces Pricing of Underwritten Offering
GlobeNewswire 01-31 Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
GlobeNewswire 2023-12-22 Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank
GlobeNewswire 2023-10-10 Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
euro adhoc 2021-09-09 EANS-News: Atrium European Real Estate Limited / Publication of Scrip Dividend Circular Q3 2021 CNE
euro adhoc 2021-06-09 EANS-News: Atrium European Real Estate Limited / Publication of Scrip Dividend Circular Q2 2021 CNE
GlobeNewswire 2021-02-09 SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 22.5 MILLION IN AN EQUITY PLACEMENT
GlobeNewswire 2021-02-09 SEQUANA MEDICAL LAUNCHES EQUITY PLACEMENT
GlobeNewswire 2020-07-07 Mid-Stabilisation Period Announcement
GlobeNewswire 2020-06-26 Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public Offering
GlobeNewswire 2020-06-24 Hyloris Pharmaceuticals Announces Narrowing of Price Range of its Initial Public Offering
GlobeNewswire 2020-06-19 Hyloris Pharmaceuticals Announces Coverage of the Maximum Offering Size, including Increase Option a...
GlobeNewswire 2020-06-18 Hyloris Pharmaceuticals Announces the Coverage of the Base Offering Throughout the Price Range of it...
GlobeNewswire 2020-06-17 Hyloris Pharmaceuticals launches its Initial Public Offering on Euronext Brussels
GlobeNewswire 2020-06-03 Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussel...
GlobeNewswire 2020-01-22 Sequana Medical Successfully Raises Eur 19.0 Million in an Equity Placement
GlobeNewswire 2020-01-22 SEQUANA MEDICAL LAUNCHES EQUITY PLACEMENT
GlobeNewswire 2019-06-07 Van Lanschot Kempen completes share buy-back programme
GlobeNewswire 2019-06-04 Van Lanschot Kempen: update on share buy-back programme 28 May 2019 - 3 June 2019